17th Community Wide Experiment on the
Critical Assessment of Techniques for Protein Structure Prediction
Target List csv
Targets are released at 9:30 am Pacific time (PDT=GMT-7hours) and expire at 9:00 am PDT.

Predictions in special categories, where a large number of models is requested, should be submitted before the Soft Deadline (typically 2 days before the Human Expiration) as submissions in these categories will not be checked immediately upon acceptance, but shortly afterwards. If model(s) have formatting issues, you will get a message from us within a few hours after the Soft Deadline so that you will have a chance to resubmit models before the Human Expiration deadline.

Green color - active target; Yellow color - target expires within 48 hours; Orange color - target expires within 24 hours
Nucleic acid-containing complexes are highlighted with the light grey background.

Target type 'h' is for human targets, 's' for server-only targets.
Target naming convention: Txxxx - protein monomers/homomers; Hxxxx - protein heteromers; Rxxxx - RNA monomers/homomers; Dxxxx - DNA monomers/homomers; Mxxxx (hybrid) - nucleic acid-containing hetero-complexes (with or without protein); Lxxxx - ligand only targets.
Stoichiometry 'UNK' stands for UNKNOWN.
* CAPRI target

All targets Mono/Homo -mers Multimers RNA Ligand Ensemble
Phase 1 | 2 | all Phase 1 | 2 | all Phase 1 | 2 | all Phase 1 | 2 | all
#
Tar-id
Type
Res
Stoichiom.
Entry    
Date
Server
Expiration
Soft
Deadline
Human
Expiration
QA
Prediction
Description
1. R2303 s NucA 84 A2 2026-04-28 2026-04-30 2026-04-30 2026-04-30 - Eterna ZG_113_EliFisker_F_10
2. R2305 s NucA 105 A2 2026-04-29 2026-05-01 2026-05-01 2026-05-01 - MPNN-RFdiff design
3. M2310 s Hybrid /Ensmbl 810 A1B1 2026-05-01 2026-05-05 2026-05-05 2026-05-05 - B.a. group IIB2 intron postcat
4. M2320 s Hybrid 731 A1B1 2026-05-06 2026-05-10 2026-05-10 2026-05-10 - C.tet group IIB intron
5. H2324 * h Prot 856 A1B1C1D1E1 2026-05-07 2026-05-10 2026-05-21 2026-05-21 from: 2026-05-21
to: 2026-05-24
T Cell Receptor N17.2, complex (5 chains)
6. R2323 s NucA /Ensmbl 83 A2 2026-05-07 2026-05-09 2026-05-14 2026-05-14 - RNA - miniTTR-11 WT
7. R2325 s NucA 499 A2 2026-05-08 2026-05-11 2026-05-11 2026-05-11 - O.i. group II intron dimer
8. H2312 * h Prot 1409 A1B1C1 2026-05-13 2026-05-16 2026-05-27 2026-05-27 from: 2026-05-27
to: 2026-05-30
EXT1-EXT2-2BAV4
9. M2333 s Hybrid 614 A1B1 2026-05-13 2026-05-15 2026-05-15 2026-05-15 - TaitIntron RNA
10. H2338 * h Prot 1050 A1B1C1D1 2026-05-14 2026-05-17 2026-05-21 2026-05-29 from: 2026-05-29
to: 2026-06-01
Factor XIa antibody complex 9933
11. M2334 s Hybrid 1204 A1B1 2026-05-14 2026-05-16 2026-05-16 2026-05-16 - TaitIntron RNP
12. T2313 * h Prot 618 A3 2026-05-14 2026-05-17 2026-05-28 2026-05-28 from: 2026-05-28
to: 2026-05-31
P66
13. H2339 * h Prot 1044 A1B1C1D1 2026-05-15 2026-05-18 2026-05-22 2026-05-30 from: 2026-05-30
to: 2026-06-02
Factor XIa antibody complex 7508
14. M2337 s Hybrid 644 A1B1 2026-05-15 2026-05-18 2026-05-22 2026-05-22 - Pli Group IIB intron postcat
15. H2319 * h Prot 497 A2B2C2 2026-05-19 2026-05-22 2026-06-02 2026-06-02 from: 2026-06-02
to: 2026-06-05
Human astrovirus VA1 capsid spike - antibody 7C8 complex
PDB code 9oef
16. H2321 * h Prot 502 A2B2C2 2026-05-20 2026-05-23 2026-06-03 2026-06-03 from: 2026-06-03
to: 2026-06-06
Human astrovirus VA1 capsid spike - antibody 2A2 complex
PDB code 9oeg
17. H2335 * h Prot 1820 A1B1C1D1E1 2026-05-27 2026-05-30 2026-06-10 2026-06-10 from: 2026-06-10
to: 2026-06-13
HCMV Merlin gHgLgO-Fab complex
18. H2340 * h Prot 686 A3B3C3 2026-06-01 2026-06-04 2026-06-15 2026-06-15 from: 2026-06-15
to: 2026-06-18
Parahenipavirus F protein /antibody complex
19. H2343 * h Prot 773 A1B1C1 2026-06-01 2026-06-04 2026-06-15 2026-06-15 from: 2026-06-15
to: 2026-06-18
Hepatitis C Virus sE2 CBH-4G Fab complex
20. E2366 h Prot /Ensmbl 1269 A3 2026-06-02 2026-06-09 2026-07-14 2026-07-16 - S-PRD0038-WT
21. E2367 h Prot /Ensmbl 1269 A3 2026-06-02 2026-06-09 2026-07-14 2026-07-16 - S-PRD0038-D603G
22. T2342 * h Prot 1455 A3 2026-06-02 2026-06-05 2026-06-16 2026-06-16 from: 2026-06-16
to: 2026-06-19
Spike glycoprotein ectodomain
23. E2368 h Prot /Ensmbl 1269 A3 2026-06-03 2026-06-10 2026-07-15 2026-07-17 - S-PRD0038-Q617K
24. E2369 h Prot /Ensmbl 1269 A3 2026-06-03 2026-06-10 2026-07-15 2026-07-17 - S-PRD0038-D603G-Q617K
25. H2344 * h Prot 734 A1B1C1 2026-06-03 2026-06-06 2026-06-17 2026-06-17 from: 2026-06-17
to: 2026-06-20
HSV gD - HAB72
26. H2346 * h Prot 885 A1B1C1D1 2026-06-04 2026-06-07 2026-06-18 2026-06-18 from: 2026-06-18
to: 2026-06-21
REGN3753 Fab-Fab complex
27. H2347 * h Prot 876 A1B1C1D1 2026-06-04 2026-06-07 2026-06-18 2026-06-18 from: 2026-06-18
to: 2026-06-21
REGN15499 Fab-Fab complex
28. H2348 * h Prot 1034 A1B1C1 2026-06-05 2026-06-08 2026-06-19 2026-06-19 from: 2026-06-19
to: 2026-06-22
gp130 antibody complex
29. H2349 * h Prot 1030 A1B1C1 2026-06-05 2026-06-08 2026-06-19 2026-06-19 from: 2026-06-19
to: 2026-06-22
gp130 antibody complex
30. H2354 * h Prot 726 A3B3C3 2026-06-08 2026-06-11 2026-06-22 2026-06-22 from: 2026-06-22
to: 2026-06-25
hemagglutinin/antibody
31. H2355 * h Prot 708 A3B3C3 2026-06-08 2026-06-11 2026-06-20 2026-06-22 from: 2026-06-22
to: 2026-06-25
hemagglutinin/antibody
32. E2375 h Prot /Ensmbl 668 A3B3 2026-06-09 2026-06-16 2026-07-21 2026-07-23 - HIV-1 envelope protein complex B37B
33. E2376 h Prot /Ensmbl 662 A3B3 2026-06-09 2026-06-16 2026-07-21 2026-07-23 - HIV-1 envelope protein complex B42A
34. H2356 h Prot 590 A8B4 2026-06-09 2026-06-12 2026-06-21 2026-06-23 from: 2026-06-23
to: 2026-06-26
A0A517IGU2, A0A517I5H8
35. H2359 * h Prot 2336 A1B1C1D1E1F1 2026-06-10 2026-06-13 2026-06-22 2026-06-24 from: 2026-06-24
to: 2026-06-27
A0AB35JLN2, A0AAE5SBF7, A0A2S4JD57, A0A0Q0BBX2, A0A1A6E3L8, A0ABT2VBN8
36. T2358 s Server only 151 A2 2026-06-10 2026-06-13 2026-06-13 2026-06-13 - A7XXF0_BP234
37. H2360 * h Prot 1558 A1B1C1D1E1 2026-06-11 2026-06-14 2026-06-23 2026-06-25 from: 2026-06-25
to: 2026-06-28
P69905, P68871
38. H2362 * h Prot 1836 A1B1C1D1E1F1G1 2026-06-12 2026-06-15 2026-06-24 2026-06-26 from: 2026-06-26
to: 2026-06-29
HCMV with a FAB
39. T2364 h Prot 86 A3 2026-06-15 2026-06-18 2026-06-29 2026-06-29 from: 2026-06-29
to: 2026-07-02
A0A178UXU6
40. T2395 h Prot 176 A5 2026-06-18 2026-06-21 2026-06-30 2026-07-02 from: 2026-07-02
to: 2026-07-05
Ab CSUA1 Fiber
41. T2371 * h Prot 151 A2 2026-06-19 2026-06-22 2026-07-03 2026-07-03 from: 2026-07-03
to: 2026-07-06
Q8TW57
42. H2373 * h Prot 725 A1B1C1 2026-06-22 2026-06-25 2026-07-06 2026-07-06 from: 2026-07-06
to: 2026-07-09
HSV-2 gD - HAB194
43. H2374 * h Prot 739 A1B1C1 2026-06-22 2026-06-25 2026-07-06 2026-07-06 from: 2026-07-06
to: 2026-07-09
HSV-2 gD - HAB13
44. M2377v1 h Hybrid /Ensmbl 462 A2B1 2026-06-24 2026-06-27 2026-07-08 2026-07-08 from: 2026-07-08
to: 2026-07-11
P15692-4 / 2XP
45. M2377v2 h Hybrid /Ensmbl 462 A2B1 2026-06-24 2026-06-27 2026-07-08 2026-07-08 from: 2026-07-08
to: 2026-07-11
P15692-4 / 2XP
Protein Structure Prediction Center
Sponsored by the US National Institute of General Medical Sciences (NIH/NIGMS)
Please address any questions or queries to:
© 2007-2026, University of California, Davis
Terms of Use